Therapeutic Lenses Market Size (2024 - 2029)

The therapeutic lenses market is projected to experience significant growth, driven by an increasing prevalence of eye diseases, diabetes, and the adoption of advanced premium intraocular lenses. Despite the initial decline in market size due to the COVID-19 pandemic, the market is expected to recover and reach pre-pandemic growth levels. Regions with high rates of unaddressed vision impairment, particularly in low- and middle-income areas, are anticipated to contribute substantially to market expansion. However, challenges such as the high cost and poor quality of lenses may hinder market growth.

Market Size of Therapeutic Lenses Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Therapeutic Lenses Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 8.50 %
Fastest Growing Market North America
Largest Market Asia-Pacific
Market Concentration Medium

Major Players

Therapeutic Lenses Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Therapeutic Lenses Market Analysis

The therapeutic lenses market is expected to register a CAGR of 8.5% during the forecast period.

The number of patients undergoing ophthalmology procedures at the hospital declined during the COVID-19 pandemic, significantly hampering therapeutic lens usage. For instance, according to a research study published by the Indian Journal of Ophthalmology in June 2021, the studied clinics were expected to perform 7,500 cataract procedures. Still, due to the pandemic, they could perform only 2,500 procedures. This data suggests a significant decrease in cataract procedures during the COVID-19 pandemic. Furthermore, as per the research study published by Dovepress in November 2021, on the comparison of the pre-pandemic and pandemic periods data for glaucoma patients in a tertiary centre, it was observed that the total number of outpatient clinical visits, visual field exams, surgical procedures, and medications released decreased by 92.52%, 93.84%, 72.74%, and 19.63%, respectively. Thus, the COVID-19 outbreak affected the market's growth significantly; however, as the pandemic has currently subsided, the market is expected to experience pre-pandemic growth levels during the study's forecast period.

The market is driven by factors such as the increasing burden of eye diseases, the increasing prevalence of diabetes and cataracts, and the rising adoption of advanced premium intraocular lenses (IOLs).

According to the World Health Organization October 2021 update, in low- and middle-income regions, the prevalence of distance vision impairment is estimated to be four times higher as compared to the high-income areas, while, in terms of near vision impairment, rates of unaddressed close vision impairment are estimated to be greater than 80% in western, eastern and central sub-Saharan Africa, while comparative rates in high-income regions of North America, Australasia, Western Europe, and of Asia-Pacific are reported to be lower than 10%. Thus, these regions may emerge as significant growth regions for the therapeutic lens market over the forecast period of the study.

Moreover, the growing burden of cataracts and diabetes is anticipated to drive the demand for therapeutic lenses market. According to the October 2021 statistics by the HelpMeSeeIndia Foundation, cataract contributes to 66.2% of overall blindness in people between 50-90 years of age. In Addition, as per the September 2021 report of the International Diabetes Federation, diabetes affected approximately 537 million persons aged 20 to 79 in 2021. The total number of people with diabetes was expected to reach 643 million by 2030 and 783 million by 2045. Three out of every four adults with diabetes lived in low- and middle-income nations. Therefore, people with diabetes are more likely to develop eye diseases, which is predicted to increase demand for therapeutic lenses and stimulate market expansion.

Thus, all aforementioned factors such as the high burden of eye diseases are expected to boost market growth over the forecast period. However, poor quality and high cost of the lens are expected to restrain the market growth over the forecast period.

Therapeutic Lenses Industry Segmentation

As per the scope of the report, therapeutic lenses are intended to stop the mechanical rubbing of the blinking eyelids on a cornea that has been damaged or infected, allowing the cornea to heal. A wide range of corneal conditions, including bullous keratopathy, corneal erosions, corneal epithelial defects, and postsurgical conditions like post-keratoplasty and post-laser vision correction, can be treated with therapeutic lenses. The therapeutic contact lenses market is segmented by product (intraocular lenses, progressive lenses, others), application (myopia, presbyopia, corneal surgery/disorders, post-ocular surgery, drug delivery, others), end user (hospitals, ambulatory centers, other end users), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America).. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product Type
Intraocular Lenses
Monofocal Intraocular Lens
Accommodative Intraocular Lens
Multifocal Intraocular Lens
Toric Intraocular Lens
Progressive Lenses
Others
By Application
Myopia
Presbyopia
Corneal Surgery/Disorders
Post Ocular Surgery
Drug Delivery
Others
By End User
Hospitals
Ambulatory Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Therapeutic Lenses Market Size Summary

The therapeutic lenses market is poised for significant growth, driven by an increasing prevalence of eye diseases, diabetes, and cataracts. The market experienced a temporary setback during the COVID-19 pandemic due to a decline in ophthalmology procedures, but it is expected to rebound to pre-pandemic growth levels. The rising adoption of advanced premium intraocular lenses (IOLs) and the growing burden of cataracts and diabetes are key factors propelling market expansion. Regions with high rates of unaddressed vision impairment, particularly in low- and middle-income areas, are anticipated to emerge as significant growth markets. The demand for therapeutic lenses is further bolstered by the high prevalence of presbyopia and the introduction of innovative products by major market players.

North America is expected to maintain a stronghold in the therapeutic lenses market, supported by its advanced healthcare system and robust research and development activities. The region's market growth is driven by the increasing acceptance of therapeutic lenses and the rising prevalence of eye diseases. The market is moderately fragmented, with key players like Alcon Inc., Bausch Health Companies Inc., and Hoya Corporation employing strategies such as strategic acquisitions, collaborations, and product innovations to strengthen their market position. Recent developments, including product launches and regulatory approvals, underscore the dynamic nature of the market, with companies focusing on developing efficient and cost-effective therapeutic lenses to meet growing patient demands.

Explore More

Therapeutic Lenses Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Burden of Eye Diseases

      2. 1.2.2 Increasing Cases of Cataracts in the Diabetic Population

      3. 1.2.3 Rising Adoption of Advanced Premium IOLs

    3. 1.3 Market Restraints

      1. 1.3.1 Poor Quality and High Cost of Lens

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value USD)

    1. 2.1 By Product Type

      1. 2.1.1 Intraocular Lenses

        1. 2.1.1.1 Monofocal Intraocular Lens

        2. 2.1.1.2 Accommodative Intraocular Lens

        3. 2.1.1.3 Multifocal Intraocular Lens

        4. 2.1.1.4 Toric Intraocular Lens

      2. 2.1.2 Progressive Lenses

      3. 2.1.3 Others

    2. 2.2 By Application

      1. 2.2.1 Myopia

      2. 2.2.2 Presbyopia

      3. 2.2.3 Corneal Surgery/Disorders

      4. 2.2.4 Post Ocular Surgery

      5. 2.2.5 Drug Delivery

      6. 2.2.6 Others

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Centers

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Therapeutic Lenses Market Size FAQs

The Global Therapeutic Lenses Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)

Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Carl Zeiss Meditec AG and Johnson and Johnson Vision Care Inc. are the major companies operating in the Global Therapeutic Lenses Market.

Therapeutic Lenses Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)